In particular, during the initial years of antiretroviral treatment the clinicians were more concerned about HIV progression than HCV co-infection; further, anti HCV drugs, in particular interferon, were not indicated in patients with low CD4 counts and this could explain the low number of treated individuals. This evidence concerns the gene CD4 and coinfection.